The synthesis and distribution of hyaluronate and proteoglycan were studied in bovine articular cartilage in short-term explant culture with [3H] medium and tissue by cartilage from either the superficial layer or the deep layer of articular cartilage. When articular cartilage was incubated with 0.4 mM-cycloheximide, proteoglycan synthesis was markedly inhibited, whereas the synthesis of hyaluronate was only partially inhibited and resulted in more of the newly synthesized hyaluronate being released into the medium. Analysis of the hydrodynamic size of [3H]hyaluronate isolated from cartilage on Sephacryl-1000 revealed one population that was eluted as a broad peak (Kav < 0.7), compared with two populations (Kav > 0.5 and < 0.5) appearing in the medium of cultures. These data suggest that hyaluronate is synthesized in excess of proteoglycan synthesis and that the hyaluronate that is not complexed with proteoglycans is rapidly lost from the tissue.
INTRODUCTION
The extracellular matrix of articular cartilage is made up of collagen, proteoglycans, matrix proteins and hyaluronate. The collagen (type II collagen) meshwork provides the cartilage with its structural integrity and entraps proteoglycan aggregates, which provide cartilage with its unique ability to withstand compression (Handley et al., 1985) . These matrix components are not metabolically passive, but are constantly being turned over, this process being controlled and maintained by the chondrocytes (Handley et al., 1986) . Perturbation of this steady-state condition, such as occurs in degenerative and diseased cartilage, will result in the loss of biomechanical function of the tissue (Kempson, 1980) . It is therefore important that the concentration of these macromolecules in the matrix be kept at a level that allows the articular cartilage to maintain its biomechanical role.
Proteoglycans and link proteins are synthesized within the endoplasmic reticulum of the chondrocytes before being released into the extracellular matrix (Handley et al., 1985) . Synthesis of hyaluronate, on the other hand, is believed to occur on plasma membrane of chondrocytes, and the enzyme responsible for chain elongation is hyaluronate synthetase, an integral plasma-membrane protein (Prehm, 1984) . Newly synthesized hyaluronate remains attached to the synthetase during synthesis via a phosphodiester bond, and, upon completion of chain elongation, the bond is cleaved, releasing hyaluronate into the matrix. In articular cartilage newly released hyaluronate is probably utilized for the formation of aggregates with proteoglycans and link proteins. In the present paper the kinetics of hyaluronate synthesis by and release from bovine articular cartilage in explant culture are investigated.
Methods
Cartilage cultures. Bovine articular cartilage was isolated from metacarpal-phalangeal joints as previously described (Hascall et al., 1983) . Tissue slices (approx. 100 mg/vial) were distributed into pre-weighed sterile plastic vials and maintained at 37°C for a predetermined period of time in 4 ml of Dulbecco's modified Eagle's medium with or without 20% (v/v) fetal-calf serum (Handley & Lowther, 1977) . In some experiments where a large batch of labelled cartilage was required, 1 g of tissue was incubated in 10 ml of medium. In other experiments the superficial layer ofcartilage was dissected from the deep layer adjacent to the subchondral bone; tissue (approx. 100 mg) from each layer was distributed separately into vials as described above.
Incubation of articular cartilage with radiolabelled precursors. Cartilage cultures were preincubated in fresh medium containing 200 fetal-calf serum with 0.5 mmsodium acetate for 1 h, and this medium was replaced with 2 ml of labelling medium containing H235SO4 (20 ,uCi/ml) and/or [3H]acetate (30 ,uCi/ml). Tissue was incubated for a predetermined period of time at 37°C in a shaking water bath before being digested with papain. In the pulse-chase experiments, tissue was incubated with [3H]acetate (30 ,uCi/ml) and [35S] sulphate (20 ,tCi/ ml) for 6 h, then washed with fresh medium before being incubated with medium not containing label for up to 6 h. In experiments in which cycloheximide was used, cartilage was preincubated at 37°C for 1 h in medium containing 20 % fetal-calf serum, then with fresh medium containing 200% fetal-calf serum, [3H]acetate (30 , uCi/ml), [35S] sulphate (20 ,tCi/ml) and 0.4 mMcycloheximide (McQuillan et al., 1984) . The time of this addition was designated zero time. Duplicate cultures were removed at predetermined times, and the reactions were stopped by addition of 2 ml of 0.1 M-sodium acetate buffer, pH 5.5, containing 5 mM-EDTA and 5 mmcysteine hydrochloride.
Isolation of glycosaminoglycans. Depending on the experiment, tissue and medium were digested with papain either separately or together. Papain digestion of the tissue was carried out by adding 2.0 ml of 0.1 M-sodium acetate buffer, pH 5.5, containing 5 mM-EDTA, 5 mmcysteine hydrochloride and 1.4 ,ug of papain (Handley & Lowther, 1977) . Medium was adjusted to 0.1 M-sodium acetate buffer, pH 5.5, containing 5 mm-EDTA and 5 mM-cysteine hydrochloride, and 1.4,g of papain was added. Digestions were carried out at 60°C for 16 h, and the resulting glycosaminoglycans were subjected to ionexchange chromatography on a Mono-Q column.
Ion-exchange chromatography on Mono-Q. A prepacked Mono-Q column (HR 5/5) was pre-equilibrated in 0.15 M-LiCl/0.06 M-imidazole/HCl buffer, pH 6.0, at a flow rate of 1 ml/min. Papain-digested samples were centrifuged at 10000 g for 3 min, and the resulting supernatants (1.5 ml) were applied to the column. (Hascall & Kimura, 1982) together with 10 mM-mannitol and exogenous hyaluronate (2 mg/ml) for 60 h at 4 'C. Mannitol was added as an oxy radical scavenger (Bates et al., 1984) . Samples of the medium and tissue extracts were applied to columns (0.8 cm x 15 cm) of Sephadex G-50 equilibrated with 7 M-urea/0.05 M-sodium acetate buffer, pH 6.0, containing 0.15 M-NaCl and 0.500 Triton X-100. Labelled macromolecules recovered in the excluded volume were separated by ion-exchange chromatography on a DEAESephacel column (0.5 cm x 8 cm) with a linear gradient of NaCl (0.15-1.4 M over 220 ml) in 7 M-urea/0.05 Msodium acetate buffer, pH 6.0, containing 0.5 % Triton X-100 (Yanagishita & Hascall, 1985) .
Fractions containing 3H-labelled hyaluronate were pooled and applied to a Sephacryl-1000 column (0.4 cm x 84 cm) equilibrated with 1.0 M-NaCl/0.05 Msodium acetate buffer, pH 6.0, containing 0.05 % (w/v) CHAPS. Each fraction was assayed for radioactivity. The molecular mass of [3H]hyaluronate eluted from the Sephacryl-1000 column was estimated from selectivity curves supplied by the manufacturer. Samples of the hyaluronate peak were applied to columns (0.8 cm x 15 cm) of Sephadex G-50 equilibrated with 50 mM-NH4HCO3. The radiolabelled material eluted at the void volume of the column was pooled and freezedried before being made up in 0.15 M-NaCl/0.02 Msodium acetate buffer, pH 6.0. A portion of each sample was treated with Streptomyces hyaluronidase (0.1 unit), before analysis on the Sephacryl-1000 column as described above or on a column (0.8 cm x 15 cm) of Sephadex G-50 eluted with 1.0 M-NaCl/0.05 M-sodium acetate buffer, pH 6.0, containing CHAPS. (Fig. 2a) , except that hyaluronate synthesis showed a marked lag at the beginning of the incubation. About 9500 of the total 3H-or 35S-labelled sulphated glycosaminoglycans were retained in the tissue, and the remainder was found in the medium (Fig. 2b) (Fig. 2b) (Fig. 3) . A little more [3H]hyaluronate accumulates in the medium during the first 1 h of chase, but thereafter there is very little further loss from the tissue. Thus the fraction of [3H]hyaluronate destined for the medium is rapidly lost to the medium soon after synthesis. 3H-labelled sulphated glycosaminoglycans were found to be retained predominantly in the matrix, although there was a very slow release of sulphated glycosaminoglycans from the matrix to medium with time. 35S-labelled glycosaminoglycans showed a similar distribution to 3H-labelled sulphated glycosaminoglycans.
RESULTS
Effect of cycloheximide on hyaluronate and proteoglycan synthesis The observations described above indicate that part of the newly synthesized hyaluronate is retained within the matrix of articular cartilage, most probably in the form ofcomplexes with proteoglycan subunits. To test whether the proportion of hyaluronate lost to the medium increases when proteoglycan synthesis is decreased, articular cartilage was preincubated in Dulbecco's modified Eagle's medium containing 200% fetal-calf serum plus 0.5 mM-sodium acetate for I h, then incubated for up to 6 h in the same medium containing [3H]acetate and [35S]sulphate in the presence and in the absence of0.4 mMcycloheximide. Synthesis of 3H-labelled sulphated glycosaminoglycan was markedly decreased in cultures maintained with cycloheximide (Fig. 4a) . This reflects the gradual depletion of the intracellular proteoglycan coreprotein pool as the result of the inhibition of mRNA translation. The half-life of the pool was estimated to be 36 min from a semi-logarithmic plot of the data (Fig. 4a  inset) . The effect of cycloheximide on total hyaluronate synthesis is shown in Fig. 4(b) Size of I3Hlhyaluronate in tissue and medium After preincubation in Dulbecco's modified Eagle's medium containing 200 fetal-calf serum for 1 h, 1 g of articular cartilage was incubated in the same medium containing [3H]acetate for 6 h. Since papain digestion alters the size of hyaluronate, this method cannot be used to estimate the size of hyaluronate in the tissue or the medium. After labelling, tissue was exctracted with 4 Mguanidinium chloride in the presence of inhibitors and mannitol as outlined in the Experimental section. Approx. 250 of the total [3H]hyaluronate was extracted from the tissue by this procedure. Extracts were then passed down a Sephadex G-50 column to exchange the guanidinium chloride-containing buffer for ureacontaining buffer and to remove unincorporated radiolabelled precursors. The [3H]acetate-labelled macromolecules appearing in the void volume of this column were applied to a DEAE-Sephacel column, which was eluted with a linear salt gradient.
3H-labelled hyaluronate fractions from tissue and medium that were eluted from DEAE-Sephacel at the same position as standard [3H]hyaluronate (0.17-0.19 MNaCl) were analysed by gel filtration on Sephacryl-1000. Fig. 6 shows that [3H]hyaluronate from the tissue was eluted as a single broad peak (Kav 0.03-0.63) that was totally digested by Streptomyces hyaluronidase. 3H-labelled hyaluronate was also isolated from cartilage by digestion with papain in the absence of EDTA and cysteine as described by Holmes et al. (1988) , and when this was analysed on Sephacryl-1000 a similar profile was obtained to that for hyaluronate extracted from the tissue with guanidinium chloride. Medium [3H]-hyaluronate separated into two populations, 4500 of the total 3H-labelled material having a Kav of 0.5 or less (peak I) and the remaining 3H-labelled material having a Kay of 0.5 or more (peak II). Fractions corresponding to the two peaks were pooled separately, and treated with Streptomyces hyaluronidase as described in the Experimental section before being analysed on Sephadex G-50. Both peaks were readily digested with the enzyme to yield hexa-and tetra-saccharides. (Holmes et al., 1988) . The cleavage of molecules is limited in young human cartilage, yielding resident molecules of similar size to those of the bovine peak I hyaluronate (Fig. 6) . Only in very old human cartilage is cleavage sufficiently extensive to yield resident molecules of similar size to bovine peak II hyaluronate. If the latter do arise by degradation of newly synthesized larger chains, cleavage in the tissue and diffusion to the medium must be very rapid and complete, since no [3H]hyaluronate of low hydrodynamic size was found in the cartilage (Fig.  6) . No information is available for the medium ofcultured human articular cartilage (Holmes et al., 1988) . The mechanism by which cleavage could occur is not known. Direct enzymological evidence for a hyaluronidase in articular cartilage is lacking, and extensive rapid degradation by free radicals seems unlikely, since the matrix proteoglycans and culture medium would be effective scavengers in the tissue; furthermore mannitol was added to the medium before storage.
The possibility that the two distinct populations of
[3H]hyaluronate in the medium of bovine cartilage cultures arise during biosynthesis must be considered. For example, during polymerization in vitro, random chains may undergo premature termination before reaching a critical length, after which all those remaining go on to become high-molecular-mass hyaluronate. This speculation would be compatible with the non-overlapping profiles of peaks I and II (Fig. 6 ), but is contrary to the suggestion by Prehm (1983) that termination of polymerization of all hyaluronate chains is a random process. A lower rate of synthesis of hyaluronate and proteoglycan by the superficial layer of cartilage compared with tissue from the deep layer of cartilage was observed. However, there was no difference in the distribution of newly synthesized hyaluronate appearing in the medium. This suggests that, in articular cartilage from mature animals, hyaluronate is synthesized in excess over proteoglycan synthesis, thereby producing a surplus of hyaluronate, which rapidly moves out of the tissue. These data support the suggestion by Morales & Hascall (1988) that the proportions of hyaluronate and proteoglycan in the tissue are maintained at constant values. This unbound hyaluronate may ensure that all the proteoglycan subunits are retained in cartilage as aggregates. Furthermore this free hyaluronate may add to the pool of hyaluronate in the synovial fluid of the diarthroidal joint.
